Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy 2004 HDL CHOLESTEROL - 5th Annual Metabolic Pathways and Drug Targets Knowledge Press, March 2004, Pages: 412   Description     Table of Contents        Enquire before Buying    Send to a Friend   This publication provides the Conference Documentation for this 5th Annual Metabolic Pathways and Drug Targets Conference. High cholesterol levels remain a leading cause for atherosclerosis and other cardiovascular diseases, despite the multitude of available therapeutics. In order to develop new pharmaceutical approaches for elevating HDL it is essential to gain a greater understanding of the various pathways in HDL -C metabolism and their regulation. In it’s 5th year, this conference provides cutting-edge data on cholesterol efflux, transfer proteins, scavenger receptors, nuclear receptors, hepatic lipase, ABCA1 and apolipoprotein A. Top experts from industry and academia present powerful strategies for reducing the risk of cardiovascular diseases by improving the atherosclerotic protection. Discover the latest developments in such topics as: - The role of ceramide in the modulation of ABCA1-mediated cholesterol efflux - Understanding the regulation of HDL-C by using natural genetic variation as a tool - Analysis of SR-BI - RXR agonists as regulators for dietary cholesterol - Paraoxonase1 and it’s anti-atherosclerotic properties - LXR in lipid metabolism - HDL-raising drugs - Hepatic Lipase modulates lipoprotein metabolism - Molecular dynamics of ApoA-I - ABCA1 / apolipoprotein interactions Please Note: Documentation are copies of the conference speaker's presentation materials Customers who bought this item also bought Metabolic Syndrome: New Opportunities in Diagnostics and Therapeutics Systems Biology - Key to Unlocking the Value within the Omics Revolution Phosphatases: Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets Cell Signalling Pathways - Productive Sources of Pharmaceutical Targets Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets Proteases as Drug Targets: Technologies and Opportunities for Drug Discovery Protein-Protein Interactions as Drug Targets- Focusing On Cell Circuitry Stakeholder Insight: Metabolic Syndrome - Ticking Time Bomb

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster